Nissay Asset Management Corp Moderna, Inc. Transaction History

Nissay Asset Management Corp

$15.5 Billion
Q3 2024

A detailed history of Nissay Asset Management Corp transactions in Moderna, Inc. stock. As of the latest transaction made, Nissay Asset Management Corp holds 75,755 shares of MRNA stock, worth $2.79 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

75,755

Previous 69,033 9.74%

Holding current value

$2.79 Million

Previous $8.2 Million 38.25%

% of portfolio

0.03%

Previous 0.05%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$63.64 - $125.14 $427,788 - $841,191	6,722 Added 9.74%	75,755 $5.06 Million
Q2 2024 Aug 14, 2024	BUY	$101.21 - $166.61 $811,198 - $1.34 Million	8,015 Added 13.14%	69,033 $8.2 Million
Q1 2024 May 15, 2024	BUY	$85.37 - $115.44 $1.39 Million - $1.87 Million	16,236 Added 36.26%	61,018 $6.5 Million
Q4 2023 Feb 14, 2024	BUY	$69.51 - $104.43 $334,621 - $502,726	4,814 Added 12.04%	44,782 $4.45 Million
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $153,966 - $202,196	1,597 Added 4.16%	39,968 $4.13 Million
Q2 2023 Aug 14, 2023	BUY	$118.5 - $160.53 $21,804 - $29,537	184 Added 0.48%	38,371 $4.66 Million
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $245,680 - $356,803	-1,811 Reduced 4.53%	38,187 $5.86 Million
Q4 2022 Feb 14, 2023	SELL	$118.38 - $210.04 $125,127 - $222,012	-1,057 Reduced 2.57%	39,998 $7.18 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $123,973 - $203,889	1,050 Added 2.62%	41,055 $4.86 Million
Q2 2022 Aug 15, 2022	SELL	$117.13 - $176.59 $704,302 - $1.06 Million	-6,013 Reduced 13.07%	40,005 $5.72 Million
Q1 2022 May 16, 2022	BUY	$126.46 - $235.05 $108,755 - $202,143	860 Added 1.9%	46,018 $7.93 Million
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $958,380 - $1.56 Million	4,244 Added 10.37%	45,158 $11.5 Million
Q3 2021 Nov 10, 2021	BUY	$221.9 - $484.47 $1.65 Million - $3.6 Million	7,425 Added 22.17%	40,914 $15.7 Million
Q2 2021 Aug 13, 2021	BUY	$129.91 - $234.98 $633,571 - $1.15 Million	4,877 Added 17.05%	33,489 $7.87 Million
Q1 2021 May 11, 2021	SELL	$109.18 - $185.98 $69,438 - $118,283	-636 Reduced 2.17%	28,612 $3.75 Million
Q4 2020 Feb 08, 2021	BUY	$65.74 - $169.86 $68,435 - $176,824	1,041 Added 3.69%	29,248 $3.06 Million
Q3 2020 Oct 20, 2020	BUY	$54.34 - $94.85 $34,342 - $59,945	632 Added 2.29%	28,207 $2 Million
Q2 2020 Jul 27, 2020	BUY	$29.67 - $80.0 $818,150 - $2.21 Million	27,575 New	27,575 $1.77 Million

Others Institutions Holding MRNA

# of Institutions

954

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nissay Asset Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Nissay Asset Management Corp with notifications on news.

Account

Nissay Asset Management Corp Moderna, Inc. Transaction History